Patents by Inventor Patrick Muraca

Patrick Muraca has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170146530
    Abstract: A device, method and system for disease detection relating to the selective capture of an antigen in an analyte by a linked capture antibody, where the linked capture antibody is expressed on a nanobiosensing chip as a plurality of non-randomly oriented binding sites, within a functionalized surface, that are upwardly oriented. The device, method and system enable selective capture of an antigen in an analyte with a selectivity and sensitivity that is greater than that attainable without the plurality of non-randomly oriented binding sites that are upwardly oriented and active. The device, method and system enable selective detection of an antigen in an analyte.
    Type: Application
    Filed: November 23, 2016
    Publication date: May 25, 2017
    Inventors: Patrick Muraca, Jason Webster, Timothy Sears, James Williams
  • Publication number: 20080076134
    Abstract: The present invention includes gene and protein expression profiles indicative of whether a cancer patient is likely to respond to treatment with irinotecan. By identifying such responsiveness, a treatment provider may determine in advance those patients who would benefit from such treatment, as well as identify alternative therapies for non-responders. The present invention further provide methods of using the gene and/or protein expression profiles and assays for identifying the presence of a gene and/or protein expression profile in a patient sample.
    Type: Application
    Filed: September 21, 2007
    Publication date: March 27, 2008
    Inventor: Patrick Muraca
  • Publication number: 20060281111
    Abstract: The invention relates to novel kinase peptides and antibodies, as well as nucleic acids related to them. The peptides, antibodies and the nucleic acids are useful for the detection, staging and monitoring of the progression of a kinase-mediated disease, as well as for determining or monitoring the efficacy of treatment.
    Type: Application
    Filed: May 17, 2006
    Publication date: December 14, 2006
    Inventor: Patrick Muraca
  • Publication number: 20060263826
    Abstract: The various embodiment described herein disclose an antibody protein analysis chip. The analysis chip comprises a substrate having a plurality of layers. At least one layer is a conductive layer comprising a conductive material. The analysis chip also comprises a main channel (straight-line and S-shaped configurations) etched in the conductive layer wherein the channel begins at a loading reservoir and ends at an outlet channel. A plurality of side channels are etched in the conductive layer. The side channels are in communication with the main channel and end in a well. A plurality of wells of the analysis chip comprise at least one protein-specific antibody. In addition, a kit is disclosed comprising an embodiment of the antibody protein analysis chip.
    Type: Application
    Filed: May 18, 2006
    Publication date: November 23, 2006
    Inventor: Patrick Muraca